Diagnosis and classification of IgA nephropathy

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 556-559

  Yu, Hsin Hui ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; GLUCOCORTICOID; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT; STEROID;

ANAPHYLACTOID PURPURA; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; END STAGE RENAL DISEASE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; MEDICAL HISTORY; PATHOGENESIS; PATIENT MONITORING; PREVALENCE; PROGNOSIS; PROTEINURIA; REVIEW; RISK FACTOR; SCORING SYSTEM; STEROID THERAPY; TREATMENT RESPONSE;

GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; PROGNOSIS;

EID: 84896316223     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.030     Document Type: Review

References (38)

1. Li L.S., Liu Z.H. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 2004, 66:920-923.
2. Donadio J.V., Grande J.P. IgA nephropathy. N Engl J Med 2002, 347:738-748.
3. Allen A.C., Harper S.J., Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995, 100:470-474.
4. Suzuki H., Fan R., Zhang Z., Brown R., Hall S., Julian B.A., et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009, 119:1668-1677.
5. Wyatt R.J., Julian B.A. IgA nephropathy. N Engl J Med 2013, 368:2402-2414.
6. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000, 36:227-237.
7. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004, 24:179-196.
8. Berthoux F., Mohey H., Laurent B., Mariat C., Afiani A., Thibaudin L. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol 2011, 22:752-761.
9. Donadio J.V., Bergstralh E.J., Grande J.P., Rademcher D.M. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 2002, 17:1197-1203.
10. Radford M.G., Donadio J.V., Bergstralh E.J., Grande J.P. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997, 8:199-207.
11. D'Amico G., Minetti L., Ponticelli C., Fellin G., Ferrario F., Barbiano di Belgioioso G., et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986, 59:363-378.
12. Reich H.N., Troyanov S., Scholey J.W., Cattran D.C. Toronto glomerulonephritis R. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007, 18:3177-3183.
13. Lee S.M., Rao V.M., Franklin W.A., Schiffer M.S., Aronson A.J., Spargo B.H., et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982, 13:314-322.
14. Meadow S.R., Glasgow E.F., White R.H., Moncrieff M.W., Cameron J.S., Ogg C.S. Schonlein-Henoch nephritis. Q J Med 1972, 41:241-258.
15. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997, 29:829-842.
16. Haas M., Rahman M.H., Cohn R.A., Fathallah-Shaykh S., Ansari A., Bartosh S.M. IgA Nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant 2008, 23:2537-2545.
17. Alamartine E., Sabatier J.C., Berthoux F.C. Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis. Clin Nephrol 1990, 34:45-51.
18. Alamartine E., Sabatier J.C., Guerin C., Berliet J.M., Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991, 18:12-19.
19. Working Group of the International Ig ANN, the Renal Pathology S, Cattran D.C., Coppo R., Cook H.T., Feehally J., et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009, 76:534-545.
20. Working Group of the International Ig ANN, the Renal Pathology S, Roberts I.S., Cook H.T., Troyanov S., Alpers C.E., et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009, 76:546-556.
21. Roberts I.S. Oxford classification of immunoglobulin A nephropathy: an update. Curr Opin Nephrol Hypertens 2013, 22:281-286.
22. El Karoui K., Hill G.S., Karras A., Moulonguet L., Caudwell V., Loupy A., et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int 2011, 79:643-654.
23. Kataoka H., Ohara M., Shibui K., Sato M., Suzuki T., Amemiya N., et al. Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters. Clin Exp Nephrol 2012, 16:706-712.
24. Shima Y., Nakanishi K., Hama T., Mukaiyama H., Togawa H., Hashimura Y., et al. Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol 2012, 27:783-792.
25. Zeng C.H., Le W., Ni Z., Zhang M., Miao L., Luo P., et al. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult Chinese patients. Am J Kidney Dis 2012, 60:812-820.
26. Lee H., Yi S.H., Seo M.S., Hyun J.N., Jeon J.S., Noh H., et al. Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults. Korean J Intern Med 2012, 27:293-300.
27. Herzenberg A.M., Fogo A.B., Reich H.N., Troyanov S., Bavbek N., Massat A.E., et al. Validation of the Oxford classification of IgA nephropathy. Kidney Int 2011, 80:310-317.
28. Katafuchi R., Ninomiya T., Nagata M., Mitsuiki K., Hirakata H. Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation. Clin J Am Soc Nephrol 2011, 6:2806-2813.
29. Shi S.F., Wang S.X., Jiang L., Lv J.C., Liu L.J., Chen Y.Q., et al. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol 2011, 6:2175-2184.
30. Kang S.H., Choi S.R., Park H.S., Lee J.Y., Sun I.O., Hwang H.S., et al. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant 2012, 27:252-258.
31. Moriyama T., Nakayama K., Iwasaki C., Ochi A., Tsuruta Y., Itabashi M., et al. Severity of nephrotic IgA nephropathy according to the Oxford classification. Int Urol Nephrol 2012, 44:1177-1184.
32. Yau T., Korbet S.M., Schwartz M.M., Cimbaluk D.J. The Oxford classification of IgA nephropathy: a retrospective analysis. Am J Nephrol 2011, 34:435-444.
33. Working Group of the International Ig ANN, the Renal Pathology S, Coppo R., Troyanov S., Camilla R., Hogg R.J., et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 2010, 77:921-927.
34. Gutierrez E., Zamora I., Ballarin J.A., Arce Y., Jimenez S., Quereda C., et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 2012, 23:1753-1760.
35. Walsh M., Sar A., Lee D., Yilmaz S., Benediktsson H., Manns B., et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol 2010, 5:425-430.
36. Bellur S.S., Troyanov S., Cook H.T., Roberts I.S., Working Group of International Ig ANN, Renal Pathology S Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant 2011, 26:2533-2536.
37. Weber C.L., Rose C.L., Magil A.B. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study. Nephrol Dial Transplant 2009, 24:483-488.
38. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2012, 2:139-274.